Business
You Can Now Bet on Clinical Trial Outcomes — and Pharma Insiders Are Worried
Prediction-market firm Kalshi has opened contracts on whether drugs will hit their endpoints or win FDA approval, raising fresh insider-trading and ethics concerns.